Unknown

Dataset Information

0

Crystal structure of the complex of 2,4,6-tri-ethyl-1,3,5-tris-[(4-methyl-1H-indazol-1-yl)meth-yl]-benzene with NH4PF6.

ABSTRACT: The complex of 2,4,6-tri-ethyl-1,3,5-tris-[(4-methyl-1H-indazol-1-yl)meth-yl]-benz-ene with ammonium hexa-fluorophosphate, C39H42N6·NH4 +·PF6 -, crystallizes in the monoclinic space group P21 with two mol-ecules of the receptor, two NH4 + and two PF6 - ions in the asymmetric unit. In each of the complexes the ammonium ion resides in the cavity of the receptor mol-ecule and is fixed in its position by three N-H⋯N bonds, while the remaining hydrogen atom of the cation acts as a bifurcated binding site for N-H⋯F bonding to the counter-anion. The crystal is composed of one-dimensional supra-molecular aggregates extending along the a-axis direction.

SUBMITTER: Fuhrmann F 

PROVIDER: S-EPMC9361362 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Crystal structure of the complex of 2,4,6-tri-ethyl-1,3,5-tris-[(4-methyl-1<i>H</i>-indazol-1-yl)meth-yl]-benzene with NH<sub>4</sub>PF<sub>6</sub>.

Fuhrmann Felix F   Meier Eric E   Seichter Wilhelm W   Mazik Monika M  

Acta crystallographica. Section E, Crystallographic communications 20220712 Pt 8

The complex of 2,4,6-tri-ethyl-1,3,5-tris-[(4-methyl-1<i>H</i>-indazol-1-yl)meth-yl]-benz-ene with ammonium hexa-fluorophosphate, C<sub>39</sub>H<sub>42</sub>N<sub>6</sub>·NH<sub>4</sub> <sup>+</sup>·PF<sub>6</sub> <sup>-</sup>, crystallizes in the monoclinic space group <i>P</i>2<sub>1</sub> with two mol-ecules of the receptor, two NH<sub>4</sub> <sup>+</sup> and two PF<sub>6</sub> <sup>-</sup> ions in the asymmetric unit. In each of the complexes the ammonium ion resides in the cavity of the r  ...[more]

Similar Datasets

Unknown 2,2',2''-[(2,4,6-Trimeth-oxy-benzene-1,3,5-tri-yl)tris-(methyl-ene)]tris-(isoindole-1,3-dione).
| S-EPMC3647874 | biostudies-literature
Unknown 4,4',4''-Tris(2-pyrid-yl)-2,2',2''-[(2,4,6-trimethyl-benzene-1,3,5-tri-yl)tris-(methyl-ene)tris-(sulfanedi-yl)]tripyrimidine.
| S-EPMC2977171 | biostudies-literature
Unknown 2,4,6-Trimethyl-1,3,5-tris-(morpholino-meth-yl)benzene.
| S-EPMC2961465 | biostudies-literature
Unknown 1,3,5-Tris(bromo-meth-yl)-2,4,6-trimeth-oxy-benzene.
| S-EPMC3647873 | biostudies-literature
Unknown 5,5',5''-Triphenyl-2,2',2''-[2,4,6-tri-methyl-benzene-1,3,5-triyltris(methyl-idene-sulfanedi-yl)]tris-(1,3,4-oxadiazole).
| S-EPMC3009160 | biostudies-literature
Unknown 1,3,5-Tris{[3-(1H-benzotriazol-1-ylmeth-yl)phen-oxy]meth-yl}-2,4,6-trimethyl-benzene.
| S-EPMC2959237 | biostudies-literature
Unknown Synthesis and crystal structure of 1,3,5-tris-[(1&lt;i&gt;H&lt;/i&gt;-benzotriazol-1-yl)meth-yl]-2,4,6-tri-ethyl-benzene.
| S-EPMC11660467 | biostudies-literature
Unknown 2,4,6-Tris(2,4-dimethyl-phen-yl)-1,3,5-triazine.
| S-EPMC3344576 | biostudies-literature
Unknown 1,3,5-Tris(4-meth-oxy-phen-yl)-1,3,5-triazinane-2,4,6-trione.
| S-EPMC3998286 | biostudies-literature
Unknown 1,3,5-Tris(6-chloro-pyrazin-2-yl-oxy)benzene.
| S-EPMC2915235 | biostudies-literature